EMA Backpedaling on Protecting Trade Secret in Trials Database

International Pharmaceutical Regulatory Monitor
A A
The European Medicines Agency appears to be backing off promises to protect industry trade secrets in its new clinical trials database, and is developing scenarios under which it would release commercially confidential information.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor